Access the law at your fingertips. Contains a detailed table of contents and all rules in effect as of April 1, 2021.

Reprint of the original, first published in 1875.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

"This book comprehensively compares Georgia's new evidence code with the corresponding federal evidence rule and prior Georgia evidence law, providing detailed commentary for those new Georgia rules with federal correspondents. It takes the reader through statutory provisions in the new code from OCGA 24-1-1 through 24-10-1008. Carlson on Evidence is presented in a user friendly format, with new Georgia evidence statutes placed at the top of every page of analysis for easy access in the courtroom or office. Each rule section contains the number and text of the new Georgia evidence provisions, a summary of 2013 changes, comparison with the Federal Rules of Evidence, and federal and Georgia case law"--Publisher's website.